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 Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that 
regulates a portion of the immune response and that has been implicated in the inhibition of 
neuronal recovery following spinal cord injury.  My hypothesis is that MIF inhibits neuronal 
recovery by increasing the inflammatory response as well as the buildup of scar tissue. To test 
this hypothesis, MIF was inhibited in the lamprey after spinal cord transection via 
administration of the drug ISO-1, a small protein that inhibits the enzymatic activity of MIF. The 
behavioral recovery was then measured over thirteen week period by scoring swimming 
patterns. Axonal regeneration was measured through retrograde labeling of the somata of 
giant reticulospinal axons. Results indicate that MIF inhibition led to a 60.6% increase in axon 
regeneration, as well as more complete behavioral recovery. These results suggest the 
possibility of the MIF inhibition being a viable treatment for neural recovery following spinal 







The Vertebrate Nervous System 
 The vertebrate central nervous system is a rich, complex system that processes 
information taken in from the environment and relays commands to the rest of the body to 
ensure the coordination of organs and body parts, behavior, and consciousness. The nervous 
system comprises two main parts – the central and the peripheral nervous system (Jacobson 
2007). The central nervous system is comprised of the brain and spinal cord, and regulates 
coordination between different systems. The peripheral nervous system acts as the link 
between the CNS and the rest of the body, and is responsible for tasks such as retrieving 
sensory information, and enervating muscles to cause movement. Nerve cells, called neurons, 
are contiguous cells that relay information through a series of electrical impulses. The neuron is 
made up of three parts, the soma, the axon, and the synapse (Jacobson 2008). Somata contain 
the nucleus and other organelles. Synapses are the physical junctions between axons, long 
projections from the soma, and dendrites located on the soma of other neurons. The neurons 
of the central nervous system are surrounded by glial cells.  Glial cells are non-neuronal cells 
that have a variety of functions, providing structural, metabolic, signaling and immune support 
for the neurons (Jacobson 2008). 
 Damage to any part of the nervous system, however, can lead to disruption in the 
neural network that can adversely affect systemic processes such as metabolic functions and 
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regulation. Signaling, movement, and sensory perception can all be impaired. Injury to the 
central nervous system, and especially the spinal cord, can leave irreversible damage. 
 
Spinal Cord Injury 
Spinal cord injury can leave devastating consequences due to its disruption of vital 
systemic processes including behavior and locomotion, and a sizable proportion of the 
population suffers from the effects. The most recent results from the National Spinal Cord 
Injury Statistical Center (University of Alabama, Birmingham) reports the annual incidence of 
new spinal cord injury victims at approximately 12,000. The United States alone has about 
255,702 people who have suffered from the affliction. Though spinal cord injury may seem far 
removed from the realm of everyday life, it is in fact a very real possibility. Almost half the cases 
are due to vehicular accidents, with sports and falls as other common factors. Added to the fact 
that the average age of injury is reported to be 39.5 years, it is clear that not only can spinal 
cord injury potentially affect a large portion of the population, but it can also affect one’s 
quality of life for several decades thereafter.  
 The effects of spinal cord injury are numerous and varied, and can affect the individual 
physically and psychologically. The most evident and well-known consequences of spinal cord 
injury are paraplegia (when only the lower body is affected) and tetraplegia (the upper body 
and arms also display evidence of impaired function). When trauma is sustained at the spinal 
cord, neurons governing the sensory and motor functions of the lower body are damaged, 
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leading to loss of sensation and voluntary movement, or sometimes very jerky, uncontrollable 
movement below the site of damage. Severed axons disrupt signaling between neurons above 
and below the injury site. Axons above the lesion begin to retract towards the brain. Axons 
below begin to degenerate, resulting in a permanent impairment and possible loss of signaling 
to areas below the lesion. In the worst case, complete paralysis occurs, leaving the victim with 
greater obstacles in maintaining their independence. But there are also other associative 
complications reported consistently. On a purely physical level, victims find themselves 
suffering from urinary tract infections, spasticity, pressure ulcers, and deep vein thrombosis 
(Calandra 2003). On a psychological level, suffering, pain, and loss of independence can be 
responsible for a high incidence of depression, which only serves as yet another obstacle to 
possible rehabilitation. 
Part of what makes rehabilitation for spinal cord trauma so tricky and frustrating is the 
need to address issues on two fronts. For one, the injury itself must be healed. For example, the 
tissue damage incurred at the site of impact must be repaired, and the cellular integrity must 
be restored. But the recoupment of function further depends on the regeneration of the 
neurons that were wounded and destroyed. Severed axons between the brain and neurons 
beyond the injury site cause neuron death, the cause of paralysis. Neurons must be able to 
grow again across the injury site and reform connections in order for movement and function 





Wound Healing and Macrophage Migration Inhibitory Factor (MIF) 
 Recovering from any injury requires a careful, delicate balance in the wound healing 
process. Damaged tissue must be healed, structure must be repaired, and foreign matter that 
may infect the wound must be removed. However, an overexpression of the immune response 
can lead to inflammation, which comes with several negative consequences, including a 
number of common diseases, including sepsis, arthritis, diabetes, and atherosclerosis 
(Bennermo, et al.  2004; Dandonna et al. 2005).  
After sustaining an injury to any part of the body, including the spinal cord, the immune 
system in vertebrates is triggered. Various cellular components, including macrophages, 
microglia, and neutrophils present in the surrounding tissue are activated with spinal cord 
lesion and damage to the surrounding blood vessels and tissue (Jones et al., 2005). These 
immune cells migrate to the injury site to isolate and eliminate pathogens, and to produce pro-
inflammatory cytokines and chemokines. Cytokines and chemokines, in addition to 
upregulating immune cell presence at the injury site, also cause vasodilation, edema, and 
initiate the formation of scar tissue. This inflammatory response in vertebrates is the initial 
stage of the wound healing process, and it is triggered within minutes of the infliction (Calandra 
2003).  
The cytokine central to our study is macrophage migration inhibitory factor (MIF), which 
serves many different functions throughout the vertebrate system, including as a pituitary 
hormone and migration inhibitor (Bucala et al. 1996; Nishio et al., 2008). MIF is a cytokine 
secreted in the central nervous system by immune cells such as microglia, astrocytes, and 
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ependymal cells.  It is highly conserved across vertebrate organisms (Nishio et al., 2008). As a 
pro-inflammatory cytokine, MIF recruits and maintains the presence of immune cells that 
include, in addition to macrophages, microglia and lymphocytes at the injury site (Bucala et al. 
1996). MIF mRNA, following injury to the spinal cord, is upregulated at the wound site, setting 
off the immune response (Nishio et al., 2008). The increased presence of MIF can lead to 
overexpression of the immune response. MIF and the amassment of immune cells comprise a 
feed-forward mechanism that can result in debilitating inflammation. 
MIF is thought to be a hindrance to the wound healing process for a number of different 
reasons.  Through its partial control over the inflammatory response, MIF has been implicated 
in the activation of several pro-inflammatory pathways, as well as in the mediation of 
numerous inflammatory diseases, such as arthritis, sepsis, tissue and neuronal destruction, and 
even death (Al-Abed et al. 2005). At the inception of our study, the (possibly negative) effects of 
MIF and inflammation on axonal regeneration were unknown. At a basic level, the sheer 
volume of immune cells, dead tissue, and foreign matter at a wound site during inflammation 
can prevent axons from extending through and past the lesion (Jones et al., 2005). On a more 
pathological level, MIF production also increases in astrocytes after injury (Calandra et al., 
2003). Astrocytes are immune cells that form glial scar tissue, which is meant to contain the 
huge amount of matter present at the lesion as a result of the immune response. Scar tissue 
can also prevent effect regeneration, altering the structural integrity of the connective tissue 
and acting as physical barriers to nerve regeneration (Jones et al. 2005). The decrease of MIF 
partially inhibits scar tissue formation, suggesting that lower levels of MIF may facilitate axonal 
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growth across the lesion site by leaving a clearer path (Nishio et al. 2008). MIF has been shown 
to undergo significant up-regulation following spinal cord injury in rats, which implies that 
decreasing the MIF present directly after spinal cord injury may affect rehabilitation 
(Hashimoto, 2005).  Together, these data implicate MIF as a negative factor for neuron repair 
and regeneration after spinal cord injury.  Therefore, my hypothesis is that inhibiting MIF 
directly after spinal cord injury will reduce inflammation and the production of scar tissue, 
thus leading to greater axonal regeneration and more complete behavioral recovery. To do so 
I will utilize the lamprey spinal cord, which provides a robust model for recovery after spinal 
cord injury.  
 
The Lamprey as a Model Organism for Spinal Cord Research 
 For our studies, we used lamprey as a model organism.  The lamprey is the oldest living 
vertebrate, and the exact species used in this study is Petromyzon marinus, a species of sea 
lamprey (Osório, et al. 2008). The lamprey central nervous system is particularly well designed 
for neurobiological research. Larval lamprey spinal cords are long and ribbon-like, connecting 
from the brain and stretching across the length of the organism, directly above the notochord, 
a primitive vertebrate column. The spinal cord is translucent and made up of numerous smaller 
axons and several giant reticulospinal axons that travel down the spinal cord without crossing 
each other. Each axon projects from a cell body in the brain. The axons are somewhat different 
from other vertebrate axons in that it lacks a myelin sheath, which contributes to its relative 
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transparency of the spinal cord (Rovainen et al. 1967). The largest group of axons are the giant 
reticulospinal axons.  
 
Lamprey Neuroanatomy 
 There are thirty-six giant reticulospinal axons that split into two symmetrical groups on 
each side. The giant axons are labeled based on their position in the brain, and consist of M 
cells, I cells, B cells, the Mauthner, and the auxiliary Mauthner (fig. 1) (Swain et al. 1993). The 
reticulospinal axons descend from the bilateral reticular nuclei of the lamprey brain stem 
(Orlovsky, 2000; Swain, 1993). They are responsible for initiating the locomotion of the 





Figure 1: Labeled Cell Bodies of Lamprey Giant Reticulospinal Axons 
  
The lamprey is a particularly fitting organism for this study for a number of different 
reasons. The giant axons are easy to see and can be easily identified through the use of a 
dissecting microscope. Furthermore, the presence of each axon can be determined through the 
consistent arrangement of their cell bodies in the brain. The axons can be clearly labeled, 
allowing for identification throughout an experiment. Most importantly, the lamprey spinal 
cord axons have the ability to regenerate to some extent - anywhere from 10-95% of normal 
Figure 1. Labeled Cell Bodies of Lamprey 
Giant Reticulospinal Axons. Jacobs et al. 
1993. Lamprey giant reticulospinal axons are 
labeled and arranged in symmetrical groups 
throughout the brain. 
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locomotive function can be regained (Rovainen et al. 1967). After complete transection of the 
spinal cord, the severance of the giant reticulospinal axons leads to complete paralysis below 
the lesion site. However, the lamprey recovers from paralysis and regains movement after a 
period of ten to thirteen weeks (figure 2).  Anatomical investigation (figure 3) shows that the 
reticulospinal axons and synapses regenerate across the lesion site, reforming crucial 
connections, and this time course of regeneration correlates with the timing of behavioral 
recovery.  This suggests that the reticulospinal axons assist to some degree in enabling the 
lamprey to resume its locomotive capabilities (Rovainen 1976; Selzer, 1978) 
 
Figure 2: Recovery of Motor Functions after Lamprey Spinal Cord Transection 
 
 
Figure 2. Recovery of Motor Functions after 
Lamprey Spinal Cord Transection. A. Normal 
swimming behavior of the lamprey is 
characterized by sinusoidal movement. After a 
complete loss of motor functions following 
transection (marked by asterisk), the lamprey 
regains normal movement gradually over the 
course of 10-13 weeks. B. The recovery period 
was quantified with mean movement scores +/- 
SEM (n=9). (A. Foldes; P. Oliphint; J. Morgan) 
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Figure 3: Regeneration of Giant Reticulospinal Axons across Transection Site 
 
 
In addition to the characteristics of its central nervous system that make the lamprey an 
excellent model organism for this study, the lamprey also possesses a comparable immune 
system to other vertebrates. The lamprey has been shown to use many of the same cytokines 
as mice and humans, including interleukin-8, interleukin -7, nuclear factor-κB, and most 
importantly, MIF. Studying the effect of MIF on regeneration after spinal cord injury in the 
lamprey has excellent potential for a number of different reasons. The coding sequence for MIF 
is highly conserved between the lamprey and mice, rats, and humans, suggesting a high 
possibility of conservation of functions as well. In the lamprey, MIF mRNA has been shown to 
be expressed in the brain and spinal cord (figure 4), and strong expression of the protein itself 
has been found in the spinal cord.  
Figure 3. Regeneration of giant Reticulospinal 
Axons across transection site. A. Degeneration 
and Regeneration of RS axons over a 12-week 
period. B. Control spinal cord. C. Regeneration 
of RS neurons 3 weeks after spinal cord 
transection. Asterisks in C and D indicate site of 
transection. White arrows indicate terminal 
ends of giant RS axons. D. Regeneration of RS 
neurons 10 weeks after spinal cord transection.  
(P. Oliphint; B. Lau; J. Morgan) 
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MIF Expression in the Lamprey 
 MIF has enzymatic activity, which is thought to be regulated by tautomerization, and 
has been successfully inhibited by tautomerase inhibitors (Rorsman, 1996; Tracey 2005). 
Inhibition of MIF can be effectively controlled through the use of (S,R)-3-(4-hydroxyphenyl)-4,5-
dihydro-5-isoxazole acetic acid methyl ester (ISO-1), a synthetic molecule designed by the 
laboratory of Dr. Kevin Tracey (Laboratory of Biomedical Science, North Shore-Long Island 
Jewish Institute for Medical Research). ISO-1 is a small molecule that inhibits the enzymatic 
Figure 4. MIF Expression in Lamprey Brain and Spinal Cord. 
Oligonucleotides against lamprey MIF successfully amplified 183 and 
118 bp MIF fragments, and full-length (347 bp) brain and spinal cord 
cDNA libraries. This is an indication of MIF expression in both the brain 
and the spinal cord. “No Template” indicates lane where no cDNA was 




activity of MIF by binding to the active site. It has been shown to effectively inhibit lamprey MIF 
(figure 5) (Lubetsky et al., 2002). 
 







Figure 5. Inhibition of Lamprey MIF Activity through ISO-1. Increased 
tautomerase activity was exhibited with increasing levels of lamprey spinal cord 
lysate (a stimulant of enzymatic activity). The addition of ISO-1 showed 
significant inhibition of tautomerase activity.  O. Bloom; J. Morgan 
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In this experiment, following spinal cord transection in the lamprey, internal MIF will be 
inhibited via an application of ISO-1 at the lesion site. A set of control lampreys will be treated 
solely with a vehicle. Behavioral recovery will be scored over a period of thirteen week, after 
which the somata of axons that have regenerated across the lesion site will be retrogradely 
labeled. I expect that the inhibition of MIF following spinal cord injury will curtail the 















Insertion of ISO-1/Vehicle 
Twelve larval lampreys (labeled alphabetically A through L) underwent full spinal cord 
transection at the fifth gill, and all were rendered completely paralyzed below the lesion site. 
Six of the lampreys received applications of 0.1 ml of 10 mg/ml ISO-1 in 30% hydroxypropyl-β-
cyclodextrin (HBC)/2% dimethyl sulfoxide (DMSO) solution (1 mg/animal). The other six 
lampreys received only the DMSO vehicle. The drug and the control were applied through a 
small piece of GelFoam soaked in the appropriate system, which was placed at the lesion site 
before the wound was sutured. 
 
Behavioral Analysis 
The lampreys were left to recover from their transection, with careful monitoring twice 
a week for approximately 20-30 minutes. With the day of the initial transection as Day 0, each 
lamprey was observed twice a week on the fourth and seventh days of each week. Each 
lamprey was allowed to swim in a large tank, and was subject to stimulation through a tail 







• ‘0’ – Complete paralysis. Lamprey shows no response to stimuli. 
• ‘1’ – Lamprey exhibits erratic movement, often characterized by curling into a ‘C’ 
or ‘S’ shaped curve. No swimming is observed. 
• ‘2’ – Lamprey exhibits erratic movement and highly inconsistent swimming 
behavior, often in short bursts (1-15 seconds). 
• ‘3’ – Lamprey has regained some persistent swimming behavior, but movement 
is still abnormal, and there are often observable kinks in the body.  
• ‘4’ – Lamprey appears to have regained full sinusoidal movement, moving 
smoothly and swimming consistently for extended periods of time. The lamprey 
may be slow to right itself during swimming.  
Julie Schackman and I scored the twelve lampreys at separate times for a period of thirteen 
weeks, taking care not to discuss our individual scores with each other until the end of the 
experiment. The study was double-blind; the experimenter placed either ISO-1 or the vehicle at 
the lesion site of each lamprey without knowing what each lamprey received. Neither Julie nor I 
knew which lampreys had been treated with ISO-1 and which had been treated with only the 







Following the 13 week recovery period, the lampreys underwent an axon labeling 
procedure. The tracer used was horseradish peroxidase (HRP, Type IV, Sigma), which was taken 
up retrogradely through the axons to their respective cell bodies in the brain (Swain, et al. 
1993). Each lamprey was transected 3 millimeters caudal to the original transection site (the 
site of ISO-1/vehicle application). A small piece of Gelfoam, roughly 1mm
-2
 was allowed to soak 
in 40% HRP solution in lamprey internal solution (180mM KCl, 10mM HEPES, pH 7.4) solution 
for at least 1 hour in refrigeration. Following a second complete spinal cord transection, the 
Gelfoam was applied to the lesion site, and the wound was sutured.  The cut axons took up the 
HRP and retrogradely transported it to the somata in the brain over the next week.  Thus, this 
approach will only label axons that regenerated distally to the lesion site. 
After 1 week, the lampreys were sacrificed, and the brain and spinal cord were 
removed. The tissue was reacted in Hanker-Yates reagent (Sigma; 37 mg chromagen in 20 mL 
cold 0.1 M Tris buffer at pH 7.2, 0.1% hydrogen peroxide) for approximately 5-10 minutes, 
though some variability is to be expected. The tissue must be kept under careful observation 
for the duration of the reaction, and the solution should be removed after the cell body staining 
is a dark purple-brown shade and the background staining begins to darken. The tissue was 






MIF Inhibition Yield s More Complete Behavioral Recovery 
 To determine whether MIF plays a measurable role in the recovery of lamprey 
swimming behaviors after spinal cord injury, lampreys were treated with a specific inhibitor of 
MIF (ISO-1) or with vehicle alone at the time of spinal cord transection.  The lampreys were 
then allowed to recover normally for a 13 week period, and their level of movement was scored 
according to 0-4 scale described in Methods. At the end of the recovery period, the lampreys 
were revealed to either have been treated with ISO-1 or with only the vehicle. 
 The movement scores of all the lampreys over the recovery period were averaged 
according to whether it had been treated with the MIF inhibitor, ISO-1, or only with the vehicle. 
Several lampreys were not included in the final due to the possibility of inaccuracy due to 
effects unrelated to the experimental variables. For example, one lamprey exhibited a growth 
at the lesion site that caused muscle and tissue to completely choke out the lesion site and 
preclude any possibility of regeneration.  
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In examining the data, the lampreys treated with ISO-1 show a slightly higher rate of 
recovery than the lampreys treated only with the vehicle (figure 6). At maximum recovery, the 
lampreys treated with ISO-1 show a 5.2% better recovery with a peak score of 4.0 after 56 days 
of recovery. The lampreys treated only with the vehicle reach 3.8 at 91 days, a much longer 
interval. At 45 days, which is approximately halfway through the recovery period, the lampreys 


























Behavioral Recovery of MIF/Vehicle Treated Lampreys
ISO-1
Vehicle
Figure 6. Comparison of Recovery Rates. The rates of recovery for vehicle-
treated lampreys (red), +MIF inhibited lampreys (blue). 
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score of 3.25 versus 3.2 (a 1.56% increase). The ISO-1 treated lampreys reach half their 
maximum score (2.0) after 24 days of recovery. The vehicle treated lampreys reached half their 
maximum score (1.9) at approximately 25 days.   
 
MIF Inhibition Increases Reticulospinal Axon Regeneration 
To determine whether MIF plays a role in reticulospinal axon regeneration, following 
the behavioral recovery time course, RS axons in each of the 12 experimental lampreys were 
labeled with HRP using the procedures described in the Methods. The lamprey brains were 
then labeled with HRP – gelfoam saturated in 40% HRP solution was placed at a transection site 
3 mm caudal to the original site of ISO-1/vehicle application. After one week, the brains were 
then removed from each lamprey and placed in a dish to be reacted with Hanker-Yeats reagent 
(see Methods), resulting in darkly-stained somata of reticulospinal axons. The somata were 
counted and the numbers analyzed. The results are summarized in Table 1.  
This approach only allows for retrograde labeling of regenerated axons.  Therefore, 
counting the number of giant RS somata labeled with HRP is an indication of how many of these 
giant axons regenerated across the lesion site. Several lampreys were not included in the final 
analysis because the RS axons and somata of these lampreys were not successfully labeled with 
HRP, rendering them unable to be counted and included in the final data totals. Therefore, for 












In lampreys in which MIF was not inhibited and only the vehicle was present, the brain 
showed a moderate number of labeled somata. Of the lampreys treated with ISO-1 and 
undergoing MIF inhibition, a higher number of somata of giant reticulospinal axons appeared to 
be labeled. Figure 7 is side-by-side comparison of examples from each group.  
Figure 7. ISO-1 enhances the number of HRP-labeled neurons in lamprey brains, indicating greater 
axon regeneration. Green arrows indicate cell bodies of giant reticulospinal axons that were 
successfully labeled, thus indicating axonal regeneration across the lesion site. Lamprey I (left) is an 
example of a lamprey treated only with the vehicle and exhibits 13 somata of regenerated RS axons. 
Lamprey C (right) is an example of a lamprey treated with ISO-1 and is shown to have regenerated 
18 RS axons. A. Amsavelu 
24 
 
Lamprey I is an example of a lamprey brain treated only with the vehicle. Green arrows 
indicate the labeled somata, revealing the corresponding reticulospinal axons M2, M4, I2, I3, I4, 
I5, B1, and B4 on the right side and axons I2, I3, B1, B3, and B4 on the left. These 13 giant 
reticulospinal axons had regenerated across the lesion site. Lamprey C is an example of a 
lamprey that had been subject to MIF inhibition, and after reaction, the brain showed labeling 
of cells M1, M2, M3, I2, I3, I4, I5, B1, B3, and B4, and the Mauthner on the right side, and M1, 
M3, I1, I2, I3, I4, B1, B3, and the Mauthner on the left. There were a total of 18 axons that had 
regenerated across the lesion site. 
Table 1: Regenerated Axons 
 Lampr
ey 
Regenerated Axons  
(Right) 
Regenerated Axons  
(Left) 




C M1, M2, M3, I2, I3, I4, I5, B1, 
B3, B4, Mauthner 
M1, M3, I1, I2, I3, I4, B1, 
B3, Mauthner 
20 
D M2, M3, I2, I3, I4, I5, B1, B3, 
B5, Mauthner 
M2, M3, I2, I3, I4, B1, B2, 
B5, Mauthner 
19 
G M2, M3, M4, I2, I3, B4, 
Auxiliary Mauthner 





A M2, M4, I1, B1, B5, Auxiliary 
Mauthner,  
I1, I3 8 
I M2, M4, I2, I3, I4, I5, B1, B4  I2, I3, B1, B3, B4 13 
J M1, I2, I4, I5, I6, B2, B3, B4, 
Mauthner 










Analysis of the recovered lamprey brains showed a 60.6% increase from the average 
number of labeled somata of giant RS axons from lampreys treated only with the vehicle to the 
average number found in lampreys treated with MIF inhibitor (figure 8). ISO-1 treated lampreys 
had on average 17.67 ± 1.9 HRP-labeled giant RS neurons as compared with vehicle treated 
lampreys, which contained 11.00 ± 1.5 HRP-labeled giant RS neurons on average. A Student’s t-
test confirmed a significant increase between the results with p<0.05. Because the axons of 
these labeled neurons were retrogradely labeled from a position caudal to the lesion site, these 


































Figure 8. Average Number of HRP Labeled Axons. The lampreys treated 
only with the vehicle showed on average regeneration of 11.00 ± 1.5 giant 
RS axons. Lampreys treated with ISO-1 regenerated 17.67 ± 1.9 giant 
RS axons on average. 
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Figure 9: Axon Regeneration Across Cell Types 
 
 
The average percentages of axon regeneration from lampreys treated with and without 
ISO-1 were calculated according to specific cell type (Figure 9). Once again, lampreys treated 






























Giant Reticulospinal Cell Types





Figure 10: Good and Poor Regenerators 
  
 
 Several of the cell types have been identified as consistently “good” versus “poor” 
regenerators (Jacobs, et al. 1997). The Selzer lab defined good regenerators are axons that have 






























































regenerate less than 20% of the time. The results found in this experiment for the good 
regenerators - M4, I4, B2, and B6 – and the poor regenerators – M2, M3, I1, and the Mauthner 
– were grouped together to determine the existence of any correlations within the categories 
(figure10). Iso-1 enhanced the number of HRP labeled neurons, regardless of whether the 
















Corroborating Data on the Positive Effects of MIF Inhibition  
The study yielded two sets of corroborating data. On the anatomical level, labeling the cords 
that regenerated through the lesion site showed that lampreys treated with ISO-1, and thus 
exhibiting MIF inhibition, resulted in 60.6% more labeled somata than their uninhibited 
counterparts (figure 8). It is worth noting that the profile of regeneration percentages among 
specific neurons (figure 9) from the control lampreys, those treated only with the vehicle very 
closely corresponded to established values (Jacobs et al. 1997). Both the controls in this 
experiment and the controls in the Selzer study show the best relative regeneration among the 
I cells, and lower regeneration percentages among the M cells. Overall, the vehicle treated 
lampreys show lower percentages than the control lampreys in the Selzer study. The 
regeneration percentages from the ISO-1 treated lampreys, however, show higher percentages 
than the vehicle treated lampreys across the board but do not correspond to the relative levels 
of regeneration established by the Selzer lab. There is a possibility that the vehicle may have 
had a negative effect on regeneration and recovery. ISO-1 had to be dissolved in DMSO, a 
nonpolar solvent that can damage neurons and tissue. A much higher percent solution of DMSO 




Inhibition of MIF did not largely alter the intrinsic relative regenerative potential of 
specific neurons, but merely appeared to increase the incidence of regeneration across the 
board.  
 What makes the data especially compelling is that the behavioral recovery appeared to 
correspond quite well with the axonal regeneration.  The maximum recovery of the ISO-1 
treated lampreys was 11.11% higher than the maximum recovery of lampreys that had been 
treated with the vehicle alone.  
Preliminary results, when taken as a whole, support my hypothesis. MIF inhibition, and 
thus the curtailing of the inflammatory response, led to more complete behavioral recovery 
and more effective axon regeneration across the lesion site. It is worth noting that the DMSO 
vehicle may have been damaging to neurons and tissue, thus adversely affecting regeneration 
and recovery. In future trials, using a non-destructive solvent or finding an MIF inhibitor that 
can be more safely administered may in fact yield much higher recovery rates than have been 
recorded. It would also be necessary to adjust the level of inhibition through dosage of inhibitor 
in order to determine the most effective level of MIF needed for maximum recovery.  
 
 
MIF and Spinal Cord Regeneration in a Mammalian Model 
While my studies were underway, Nishio et al., 2009 published a finding that 
corroborates the results of the current experiment in lamprey.  In that study, they found that 
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the inhibition of MIF has a positive effect on neuronal recovery and regeneration (Nishio et al. 
2009). Spinal cord injury was induced in MIF knockout mice and wild-type mice, after which 
locomotive recovery was monitored over a six week recovery period. The knockout mice 
showed significantly better behavioral recovery than the wild-type mice in assessments of hind-
limb motor function. Afterwards, in-vitro glutamate assault showed significantly less death of 
cerebellar granular neurons in the knockout mice, suggesting the better possibility of recovery 
on a pathological level. Furthermore, immunohistological studies showed much higher survival 
of neurons in mice that did not produce MIF. Thus, these data collectively indicate a better 
survival of neurons after injury when MIF levels are reduced.  In light of my results in lampreys, 
another possible interpretation for enhanced recovery of motor function after SCI in the MIF 
knockout mice is an increase in axon regeneration across the injury site.  Furthermore, the 
parallels between responses to MIF inhibition in both the lamprey and the mouse model 
organisms give rise to the possibility of similar responses in higher vertebrates. There is reason 
to believe that MIF inhibition following spinal cord injury in humans may be beneficial, 
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